Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,536Revenue $M7.0Net Margin (%)-692.6Z-Score44.4
Enterprise Value $M1,399EPS $-0.6Operating Margin %-696.7F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-692.6Higher ROA y-yN
Price/Book12.310-y EBITDA Growth Rate %0Quick Ratio7.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio7.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-66.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-77.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M91.8ROI % (ttm)-34.8Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 16.5617%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 16.5610%New holding, 6310850 sh.6,310,850
KERXJohn Burbank 2012-12-31 Sold Out -0.06%$2.31 - $3.14
($2.72)
$ 16.56509%Sold Out0
KERXJohn Burbank 2012-09-30 Buy 0.06%$1.79 - $2.83
($2.08)
$ 16.56696%New holding, 500000 sh.500,000
KERXGeorge Soros 2006-09-30 Sold Out -0.04%$9.8 - $13.84
($12.1)
$ 16.5637%Sold Out0
KERXGeorge Soros 2006-06-30 Buy 0.04%$12.64 - $17.44
($15.3)
$ 16.568%New holding, 30000 sh.30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
KERX Seth Klarman 2014-06-3010,539,98611.482.6+67.01%
Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENTSUR RONCEO 2014-10-06Sell70,838$15.880.82view
Oliviero James F IIICFO 2014-10-03Sell2,694$16.14-0.81view
BENTSUR RONCEO 2014-09-12Sell50,000$14.2412.43view
Oliviero James F IIICFO 2014-09-08Sell144,237$15.880.82view
Oliviero James F IIICFO 2014-07-07Sell2,054$15.751.65view
BENTSUR RONCEO 2014-07-07Sell1,788$15.751.65view
BENTSUR RONCEO 2014-04-03Sell1,816$16.46-2.73view
Oliviero James F IIICFO 2014-04-03Sell2,087$16.46-2.73view
Oliviero James F IIICFO 2014-03-21Sell292,483$15.145.75view
BENTSUR RONCEO 2014-01-03Sell5,257$12.5727.37view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD Mar 24 2014 
    Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ Jan 06 2014 
    comment on KERX Mar 02 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Bio drug Nov 03 2011 
    comment on KERX Oct 26 2011 

    More From Other Websites
    Biotech Stock Mailbag: Keryx, Puma, Gilead, Arrowhead and Hate Mail Galore! Oct 10 2014
    Insider Trading Alert - VNTV, ENTG And KERX Traded By Insiders Oct 08 2014
    Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Ferric Citrate Covering Orally... Oct 01 2014
    Keryx Biopharmaceuticals Initiates Pivotal Phase 3 Study of Ferric Citrate for the Treatment of Iron... Sep 29 2014
    Insider Trading Alert - DVA, DATA And KERX Traded By Insiders Sep 11 2014
    Keryx Falls after Ferric Citrate's Approval with Warnings Sep 08 2014
    Keryx CEO says FDA warning label for drug is 'grossly misunderstood' Sep 08 2014
    [$$] Keryx's FDA Approval a Mixed Bag Sep 08 2014
    Why Keryx Biopharmaceuticals (KERX) Stock Is Falling Today Sep 08 2014
    Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% Sep 08 2014
    Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label Sep 08 2014
    BUZZ-U.S. Stocks on the Move-Keryx, GlaxoSmithKline, Astrazeneca Sep 08 2014
    Keryx Biopharma downgraded by FBR Capital Sep 08 2014
    Correction: Keryx-Drug Approval story Sep 06 2014
    Correction: Keryx-Drug Approval story Sep 06 2014
    FDA approves Keryx's kidney drug with warnings, shares fall Sep 05 2014
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 05 2014
    Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment... Sep 05 2014
    Keryx Finds Out That Not All FDA Approvals Are Great Wins Sep 05 2014
    Infoblox Inc. (BLOX) Climbs On Earnings Sep 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK